| Line item | 2025-12-31 FY | 2024-12-31 FY | 2023-12-31 FY | 2022-12-31 FY | 2021-12-31 FY |
|---|---|---|---|---|---|
| Revenue | – | – | – | – | – |
| Cost of Revenue | – | – | – | – | – |
| Gross Profit | – | – | – | – | – |
| Operating Expenses | $1.86M | $1.57M | $2.45M | $1.14M | $393.38K |
| R&D | – | – | – | – | – |
| SG&A | $1.86M | $1.57M | $2.45M | $1.14M | $393.38K |
| Operating Income | -$1.86M | -$1.57M | -$2.45M | -$1.14M | -$393.38K |
| Interest Expense | – | – | $203.29K | $595.12K | – |
| Tax Expense | – | – | – | – | – |
| Net Income | -$6.41M | -$4.31M | -$2.38M | -$1.49M | $1.76M |
| EPS (basic) | -2.3000 | -1.8100 | -0.2100 | 0.0000 | 0.0100 |
| EPS (diluted) | -2.3000 | -1.8100 | -0.2100 | 0.0000 | 0.0000 |
| Shares (diluted) | $2.81M | $2.38M | $11.16M | $335.78M | $374.39M |